Kahraman, D. T. Et Al. 2022. Discovery of new chiral sulfonamides bearing benzoxadiazole as HIF inhibitors for non-small cell lung cancer therapy: design, microwave-assisted synthesis, binding affinity, in vitro antitumoral activities and in silico studies. NEW JOURNAL OF CHEMISTRY , vol.46, no.6 , 2777-2791.

Kahraman, D. T., Karakucuk-Iyidogan, A., SAYGIDEĞER , Y., Oruc-Emre, E. E., Taskin-Tok, T., Basaran, E., ... Ilhan, S.(2022). Discovery of new chiral sulfonamides bearing benzoxadiazole as HIF inhibitors for non-small cell lung cancer therapy: design, microwave-assisted synthesis, binding affinity, in vitro antitumoral activities and in silico studies. NEW JOURNAL OF CHEMISTRY , vol.46, no.6, 2777-2791.

Kahraman, Demet Et Al. "Discovery of new chiral sulfonamides bearing benzoxadiazole as HIF inhibitors for non-small cell lung cancer therapy: design, microwave-assisted synthesis, binding affinity, in vitro antitumoral activities and in silico studies," NEW JOURNAL OF CHEMISTRY , vol.46, no.6, 2777-2791, 2022

Kahraman, Demet T. Et Al. "Discovery of new chiral sulfonamides bearing benzoxadiazole as HIF inhibitors for non-small cell lung cancer therapy: design, microwave-assisted synthesis, binding affinity, in vitro antitumoral activities and in silico studies." NEW JOURNAL OF CHEMISTRY , vol.46, no.6, pp.2777-2791, 2022

Kahraman, D. T. Et Al. (2022) . "Discovery of new chiral sulfonamides bearing benzoxadiazole as HIF inhibitors for non-small cell lung cancer therapy: design, microwave-assisted synthesis, binding affinity, in vitro antitumoral activities and in silico studies." NEW JOURNAL OF CHEMISTRY , vol.46, no.6, pp.2777-2791.

@article{article, author={Demet Tasdemir Kahraman Et Al. }, title={Discovery of new chiral sulfonamides bearing benzoxadiazole as HIF inhibitors for non-small cell lung cancer therapy: design, microwave-assisted synthesis, binding affinity, in vitro antitumoral activities and in silico studies}, journal={NEW JOURNAL OF CHEMISTRY}, year=2022, pages={2777-2791} }